|

CPB and Aortic Cross-Clamp Durations and ICU Length of Stay After CABG Retrospective Observational Cohort Study

RECRUITINGSponsored by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Actively Recruiting
SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Started2026-07-20
Est. completion2026-08-30
Eligibility
Age18 Years+

Summary

Cardiopulmonary bypass (CPB) and aortic cross-clamp (ACC) durations are important intraoperative factors that may influence postoperative recovery following coronary artery bypass graft (CABG) surgery. Prolonged CPB and ACC durations may be associated with increased postoperative morbidity and extended intensive care unit (ICU) stay. This retrospective observational cohort study aims to evaluate the independent associations of CPB and ACC durations with postoperative ICU length of stay in adult patients undergoing elective isolated CABG surgery. Electronic medical records of eligible patients who underwent surgery between January 1, 2019, and December 31, 2025, at a single tertiary care center will be retrospectively reviewed. Multivariable regression analyses will be performed to assess these associations after adjustment for clinically relevant potential confounders.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Age 18 years or older
* Underwent elective isolated coronary artery bypass graft surgery
* Surgery performed between January 1, 2019, and December 31, 2025
* Availability of complete electronic medical records required for the study analyses

Exclusion Criteria:

* Emergency coronary artery bypass graft surgery
* Concomitant valve surgery
* Concomitant aortic surgery
* Reoperation cases
* Incomplete study-related data
* Intraoperative death

Conditions2

Coronary Artery DiseaseHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.